Immunopathological Mechanisms Underlying Vaccine-Induced Adverse Reactions

Abstract

Vaccination engages the same innate and adaptive immune machinery that, in a minority of recipients, can produce adverse reactions ranging from immediate hypersensitivity to organ-specific autoimmunity. This article synthesizes the literature on the immunopathological mechanisms underlying the best-characterized vaccine-associated adverse reactions: anaphylaxis, driven largely by IgE-mediated or complement-mediated hypersensitivity to excipients such as polyethylene glycol; adjuvant-associated autoinflammatory phenomena captured under the proposed ASIA framework; molecular mimicry and bystander activation as routes to post-vaccination neuroimmune syndromes, most concretely demonstrated for Pandemrix-associated narcolepsy and more provisionally invoked for Guillain-Barre syndrome; myocarditis following mRNA vaccination, concentrated in young males and now linked to circulating spike antigen and innate cardiac inflammation; and vaccine-induced immune thrombotic thrombocytopenia following adenoviral-vector vaccination, mechanistically resolved within months as a platelet factor 4 autoantibody-driven syndrome analogous to heparin-induced thrombocytopenia. Read together, the evidence indicates that these syndromes are platform-specific and mechanistically distinct rather than expressions of a single generic vaccine-injury pathway, and that rapid pharmacovigilance paired with focused translational immunology can resolve even novel syndromes within a single vaccination campaign. We close by identifying where the evidence remains provisional, particularly for individual-level risk prediction and for adjuvant-associated syndromes whose population-level incidence is not yet established.